通塞脉片/胶囊治疗周围血管疾病临床应用专家共识Expert consensus on Tongsaimai Tablets/Capsules in treatment of peripheral vascular diseases in clinical practice
曹烨民;王御震;裴晓华;杨博华;赵诚;方豫东;阙华发;姜玉峰;徐旭英;夏成勇;张建强;何春红;马立人;
CAO Ye-min;WANG Yu-zhen;PEI Xiao-hua;YANG Bo-hua;ZHAO Cheng;FANG Yu-dong;QUE Hua-fa;JIANG Yu-feng;XU Xu-ying;XIA Cheng-yong;ZHANG Jian-qiang;HE Chun-hong;MA Li-ren;Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases;Xiamen Hospital of Beijing University of Chinese Medicine;Dongzhimen Hospital, Beijing University of Chi
摘要(Abstract):
通塞脉片/胶囊由金银花、当归、牛膝、党参、石斛、黄芪、玄参、甘草共8味中药组成,具有活血祛瘀、益气养阴的功效,广泛应用于周围血管疾病的治疗,临床应用40余年,积累了丰富的研究数据和应用经验。相关研究证据均表明,该药在改善周围血管疾病临床症状方面具有良好的临床疗效和药物经济学效益,同时该药也被多个专家共识、指南、教材所推荐,是目前临床上使用较多的中成药之一。为进一步提高临床医生对该药的认识,更好地指导临床合理用药,由中华中医药学会组织相关领域专家,共同起草该专家共识。该共识在临床医生问卷调查和通塞脉片/胶囊研究文献系统回顾的基础上,依据PICO化的临床问题检索文献,采用GRADE系统,基于现有最佳证据,充分结合专家经验,通过名义组法形成推荐意见或共识建议。该共识明确了通塞脉片/胶囊治疗周围血管疾病的适应症、用法用量、疗程、用药时间、合并用药和注意事项等,并说明其临床应用的安全性,适用于全国各级医院的周围血管科(血管外科)、中医外科(普外科)、内分泌科等临床医师、药师。
Tongsaimai Tablets/Capsules are composed of Lonicerae Japonicae Flos, Angelicae Sinensis Radix, Achyranthis Bidentatae Radix, Codonopsis Radix, Dendrobii Caulis, Astragali Radix, Scrophulariae Radix, and Glycyrrhizae Radix et Rhizoma, and are effective in promoting blood circulation, removing blood stasis, supplementing Qi, and nourishing Yin. It is widely used in the treatment of peripheral vascular diseases. With 40 years of clinical application, it has accumulated substantial research data and application experience. Its good clinical efficacy and pharmacoeconomic benefits in improving the clinical symptoms of peripheral vascular diseases have been confirmed by relevant research. Meanwhile, this drug has also been recommended by many expert consensus, guidelines, and teaching materials, serving as one of the most commonly used Chinese patent medicines in clinical practice. To further improve the understanding of the drug among clinicians and properly guide its clinical medication, the China Association of Chinese Medicine took the lead and organized experts to jointly formulate this expert consensus. Based on the questionnaire survey of clinicians and the systematic review of research literature on Tongsaimai Tablets/Capsules with clinical problems in the PICO framework, the consensus, combined with expert experience, concludes recommendations or consensus suggestions by GRADE system with the optimal evidence available through the nominal group technique. This consensus defines the indications, usage, dosage, course of treatment, medication time, combined medication, and precautions of Tongsaimai Tablets/Capsules in the treatment of peripheral vascular diseases, and explains the safety of its clinical application. It is recommended for clinicians and pharmacists in the peripheral vascular department(vascular surgery), traditional Chinese medicine surgery(general surgery), and endocrinology department of hospitals at all levels in China.
关键词(KeyWords):
通塞脉片/胶囊;周围血管疾病;专家共识;GRADE
Tongsaimai Tablets/Capsules;peripheral vascular disease;expert consensus;GRADE
基金项目(Foundation): 上海市卫生健康委员会“十三五”临床重点专科(中医外科)项目;; 上海市科委科研计划项目(18401932900)
作者(Authors):
曹烨民;王御震;裴晓华;杨博华;赵诚;方豫东;阙华发;姜玉峰;徐旭英;夏成勇;张建强;何春红;马立人;
CAO Ye-min;WANG Yu-zhen;PEI Xiao-hua;YANG Bo-hua;ZHAO Cheng;FANG Yu-dong;QUE Hua-fa;JIANG Yu-feng;XU Xu-ying;XIA Cheng-yong;ZHANG Jian-qiang;HE Chun-hong;MA Li-ren;Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases;Xiamen Hospital of Beijing University of Chinese Medicine;Dongzhimen Hospital, Beijing University of Chi
DOI: 10.19540/j.cnki.cjcmm.20211009.501
参考文献(References):
- [1] 中西医结合防治糖尿病足中国专家共识(第1版)[J].血管与腔内血管外科杂志,2019,5(5):379.
- [2] 谷涌泉.中国糖尿病足诊治指南[J].中国临床医生杂志,2020,48(1):19.
- [3] 陆灏,倪青,柳国斌,等.糖尿病足病中医病证结合诊疗指南[J].中医杂志,2021,62(12):1099.
- [4] 方赛男,郭宇博,刘建平,等.中成药临床应用专家共识的制订流程[J].中国中药杂志,2018,43(24):4786.
- [5] 莫美,廖星,张霄潇,等.中华中医药学会中成药临床应用专家共识报告规范[J].中国中药杂志,2019,44(12):2644.
- [6] 陈荣明,杨能华,吴亚利,等.通塞脉片对大鼠缺血后肢侧支循环建立的影响[J].南京中医药大学学报,2009,25(6):434.
- [7] 陈荣明,卞慧敏,杨能华,等.通塞脉片对大鼠缺血后肢侧支循环建立的作用及其机理探讨[J].新中医,2009,41(8):110.
- [8] 韩景献,韩力.通塞脉片治疗缺血性中风恢复期气虚血瘀证临床疗效观察[J].中西医结合心脑血管病杂志,2005,3(7):591.
- [9] 高学敏.通塞脉片临床应用概述[J].北京中医,2003,22(1):64.
- [10] 刘光大,李艳静,孙莉琼,等.通塞脉片及组方药材的化学成分研究进展[J].世界科学技术(中医药现代化),2015,17(11):2373.
- [11] 张莉,狄留庆,赵晓莉,等.高效液相色谱法测定通塞脉片中黄芪甲苷的含量[J].南京中医药大学学报,2003,19(2):94.
- [12] 张妤琳,龚丽,郭青.通塞脉片质量标准研究[J].中成药,2013,35(7):1568.
- [13] 陈锦容.通塞脉片中阿魏酸的含量测定[J].海峡药学,2009,21(8):60.
- [14] 李伟东,徐斌,狄留庆,等.RP-HPLC法测定通塞脉片不同拆方浸膏中绿原酸的含量[J].南京中医药大学学报,2003,19(1):32.
- [15] 欧阳文轩.HPLC法测定通塞脉片中β-蜕皮甾酮含量[J].亚太传统医药,2019,15(9):38.
- [16] 李伟东,狄留庆,羊亚香.复方通塞脉片提取工艺的研究[J].河北中医药学报,2004,19(4):24.
- [17] 胡玉梅,杨彪,房卉,等.通塞脉片4种入血成分的含量测定[J].世界科学技术(中医药现代化),2016,18(5):898.
- [18] 赵文秀,李妍,韩丽琴,等.通塞脉片中10种元素含量测定分析[J].广东微量元素科学,2000,7(10):66.
- [19] 韩丽琴,董顺福,王军民,等.治疗脑血管疾病中成药中金属元素的模糊分类[J].中成药,2002,24(9):50.
- [20] 陈忠航,韩丽琴,董顺福.通塞脉片、脉通胶囊中钾钠铬锰镍的分析研究[J].广东微量元素科学,2001,8(8):60.
- [21] 董宏博,董顺福,韩丽琴.通塞脉片脉通胶囊中钙镁铜锌铁的含量分析及钙/镁、铜/锌比值研究[J].微量元素与健康研究,2002,19(1):32.
- [22] 李娜,张新庄,王俨如,等.基于网络药理学方法探讨通塞脉片治疗动脉粥样硬化的作用机制[J].中国中药杂志,2016,41(9):1706.
- [23] 杨雨微,胡晨,卞慧敏,等.通塞脉片对大鼠实验性动脉粥样硬化模型血管内皮细胞的影响[J].中成药,2010,32(3):371.
- [24] 仇锦春,卞慧敏,张启春,等.通塞脉片对大鼠实验性高脂血症及动脉粥样硬化的影响[J].上海中医药杂志,2007,41(1):71.
- [25] 殷书梅,王丽英,牛金茹,等.通塞脉片治疗缺血性中风(血瘀证)的药效学研究[J].新中医,2007,39(6):106.
- [26] 张世玮,孙志广,戴敏求,等.新、老工艺通塞脉片的药理实验观察[J].江苏中医,1991(11):39.
- [27] 孙克平,吕培文.通塞脉片对早期动脉硬化闭塞症的临床观察[J].北京中医,2003,22(2):61.
- [28] 苏丽萍.通塞脉片治疗糖尿病下肢血管病变36例临床观察[J].新中医,2011,43(6):34.
- [29] 李伟浩,张韬,张学民,等.通塞脉片对糖尿病下肢动脉闭塞患者介入术后的影响[J].新医学,2021,52(4):283.
- [30] 闫少庆,柳国斌,朱忠强,等.通塞脉片联合常规疗法对糖尿病足患者炎症因子及血液流变学的影响[J].上海中医药杂志,2020,54(9):65.
- [31] 顾亚夫,赖尧基.通塞脉片治疗血栓闭塞性脉管炎的研究[J].医学研究通讯,1984(9):23.
- [32] 李娜,田明夏.通塞脉片治疗血栓闭塞性脉管炎30例[J].中医杂志,2004,45(12):940.
- [33] 任晓梅,卞卫和.通塞脉片治疗血栓性浅静脉炎30例[J].辽宁中医学院学报,2002,4(2):128.
- [34] 安兵,任晋蒙.复方三黄抗栓膏外用联合通塞脉片治疗血栓性静脉炎68例疗效观察[J].泰山医学院学报,2010,31(5):382.
- [35] 王俊志,董丽丽,王兆博.通塞脉片治疗结节性红斑临床研究[J].亚太传统医药,2016,12(13):125.
- [36] 万继峰,程玉娟,徐云燕,等.通塞脉片结合西医常规治疗脑梗死后并发下肢深静脉血栓形成疗效分析[J].上海中医药杂志,2012,46(2):41.
- [37] 赵罡.自拟消栓通脉汤治疗下肢深静脉血栓形成的效果观察[J].临床合理用药杂志,2014,7(13):76.
- [38] 国家中医药管理局.中医外科病证诊断疗效标准:ZY/T 001.2-94[S].1994.
- [39] 罗鑫.中医发展路上承载几多期待[N].健康报,2018-11-14(005).
- [40] 郑学梅.溶栓克糖口服液治疗糖尿病并动脉硬化闭塞症260例临床观察[J].河南中医,2004,24(8):23.
- [41] 杜志刚,李辉,赵宝伶,等.通塞脉片对慢性脑供血不足血管内皮功能及血栓前状态的影响[J].山东中医药大学学报,2009,33(4):302.
- [42] 黄配宜.通塞脉片治疗冠心病(气阴两虚、热毒瘀结型)60例疗效观察[J].新中医,2008,40(12):44.
- [43] 林菊香,恽文伟,梅今,等.通塞脉片治疗颈椎病120例临床观察[J].江苏中医药,2003,24(10):34.
- [44] 张德雄.通塞脉片治疗气阴两虚型膝关节骨性关节炎50例[J].南京中医药大学学报,2014,30(5):495.
- 曹烨民
- 王御震
- 裴晓华
- 杨博华
- 赵诚
- 方豫东
- 阙华发
- 姜玉峰
- 徐旭英
- 夏成勇
- 张建强
- 何春红
- 马立人
CAO Ye-min- WANG Yu-zhen
- PEI Xiao-hua
- YANG Bo-hua
- ZHAO Cheng
- FANG Yu-dong
- QUE Hua-fa
- JIANG Yu-feng
- XU Xu-ying
- XIA Cheng-yong
- ZHANG Jian-qiang
- HE Chun-hong
- MA Li-ren
- Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases
- Xiamen Hospital of Beijing University of Chinese Medicine
- Dongzhimen Hospital
- Beijing University of Chi
- 曹烨民
- 王御震
- 裴晓华
- 杨博华
- 赵诚
- 方豫东
- 阙华发
- 姜玉峰
- 徐旭英
- 夏成勇
- 张建强
- 何春红
- 马立人
CAO Ye-min- WANG Yu-zhen
- PEI Xiao-hua
- YANG Bo-hua
- ZHAO Cheng
- FANG Yu-dong
- QUE Hua-fa
- JIANG Yu-feng
- XU Xu-ying
- XIA Cheng-yong
- ZHANG Jian-qiang
- HE Chun-hong
- MA Li-ren
- Shanghai Integrated Traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of Traditional Chinese Medicine/Shanghai Institute of Integrated Traditional Chinese and Western Medicine and Vascular Diseases
- Xiamen Hospital of Beijing University of Chinese Medicine
- Dongzhimen Hospital
- Beijing University of Chi